Most of the patients in these reported cases experienced anaphylaxis within 1 hour after injection. Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and ...
The U.S. Food and Drug Administration (FDA) has added a new boxed warning to the prescribing information for glatiramer acetate, an approved injection therapy for relapsing forms of multiple ...
82 cases of anaphylaxis reported globally from 1996 to 2024, including six fatalities. New Boxed Warning added to highlight the risk of severe allergic reactions at any stage of treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback